ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,66
-0,64%
Dow Jones
40 211,72
0,00%
DAX
18 508,29
-0,49%
Brent Oil
82,885
-1,73%
Bitcoin
63 903,55
-1,46%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
20/09/201613h00Business WireTeva & Regeneron Announce Global Collaboration to Develop & Commercialize Fasinumab, an Investigational NGF Antibody for Chro...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201613h42Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201613h00Business WireTeva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201615h00Business WireTeva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) in th...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201614h00Business WireTeva to Develop Unique Wearable Tech & Machine Learning Platform for Continuous Measurement & Analysis of Huntington Disease ...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/201614h00Business WireTeva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in LondonNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/201601h01PR Newswire (US)Teva UK Study Reveals Generational 'Digital Divide' as UK Baby Boomers Fail to Embrace Benefits of 'Digital Healthcare'NYSE:TEVATeva Pharmaceutical Industries Ltd
06/09/201614h00Business WireTeva to Present at the Wells Fargo 2016 Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
30/08/201613h00Business WireTeva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/201617h50Business WireTeva to Host Generic Medicines Business Overview on September 9, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/201623h46Business WireTeva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mgNYSE:TEVATeva Pharmaceutical Industries Ltd
18/08/201609h00Business WireEuropean Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/08/201600h10Dow Jones NewsMylan Backs Year View After Sales Rise 8%NYSE:TEVATeva Pharmaceutical Industries Ltd
08/08/201623h13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/08/201614h50Dow Jones NewsAllergan Revenue Increases, Though Loss WidensNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201614h00Business WireTeva Announces Launch of Generic Gleevec® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201620h47Dow Jones NewsTeva Profit Falls on Write-DownsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201613h00Business WireTeva Reports Second Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201609h03Dow Jones NewsBusiness Watch -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201615h21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201614h40Dow Jones NewsTeva to Buy Generics Distributor Anda From Allergan for $500 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201613h00Business WireTeva Announces Acquisition of Anda Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201609h03Dow Jones NewsIn Quest to Grow, Rivals Woo Biogen -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201601h59Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h30Dow Jones NewsBiogen Attracts Takeover Interest From Two RivalsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h22Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h12Dow Jones NewsBiogen Draws Takeover Interest from Rival DrugmakersNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201620h06PR Newswire (US)Teva Completes Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201617h10Business WireCORRECTING & REPLACING Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection...NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/201615h00Business WireTeva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500mg/2 mL (250 mg...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
GHRS
GH Research
USOTC
PMCOF
Prospector Metals (QB)
BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés